Search for: "Abbott Laboratories, Inc." Results 81 - 100 of 450
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2022, 8:11 am
Author Thomas Woolner Source Wikimedia Jane LambertPatents Court (Mr Justice Mellor) Advanced Bionics AG and another v MED-El Elektromedizinische Gerate GmbH [2021] EWHC 2415 (Pat) (31 Aug 2021)In International Patent Litigation - Abbott Laboratories Ltd v Dexcom Inc. 3 March 2022 I discussed the so-called German "injunction gap" and an application to expedite the trial of a revocation action in [read post]
1 Apr 2007, 4:46 pm
Abbott Laboratories et. al. v. [read post]
4 Jan 2017, 6:44 am by Olivia Jefferson
The settlement resolved multi-year litigation originally brought by private whistleblowers as a qui tam lawsuit under the False Claims Act (FCA), centered on claims that Omnicare had violated anti-kickback laws in its dealings with Abbott Laboratories, a multinational pharmaceutical company. [read post]
21 Dec 2021, 9:24 am by Ronald V. Miller, Jr.
Our national product liability and mass tort firm is seeking potential Similac lawsuits against the formula manufacturer, Abbott Laboratories Inc., for failure to warn about the risks of NEC associated with Similac. [read post]
8 May 2007, 5:11 am
("Teva") from selling a generic version of plaintiff Abbott Laboratories' ("Abbott") antibiotic cefdinir, which it markets using the name Omnicef. [read post]
28 Apr 2010, 9:59 pm by Patent Docs
(formerly Therasense, Inc.) and Abbott Laboratories; requested a response from Defendants-Appellees Becton, Dickinson & Co., Nova Biomedical Corp., and Bayer Healthcare LLC; granted Plaintiffs-Appellants leav to file a reply; and granted the Washington Legal Foundation, Nine Intellectual Property Law Professors, Hon. [read post]
21 Oct 2008, 8:37 pm
Earlier today, October 21, 2008, the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
14 Aug 2006, 6:25 pm
The drug, sold by Abbott Laboratories, Inc., under the brand name Depakote, was found to be substantially riskier than any of the other three main epilepsy available on the market. [read post]
21 Oct 2008, 8:37 pm
Earlier today, October 21, 2008, the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
20 Oct 2009, 7:28 pm by Jeff Lowe
Abbott Nutrition, a division of Abbott Laboratories Inc., and Hospira Inc., have reported 122 incidents of fires, sparks or charring from power cords used with their devices, which include infusion pumps and adult feeding tubes. [read post]
26 Oct 2011, 7:40 am by Dr Mark Summerfield
Abbott Medical Optics, Inc v Alcon Laboratories, Inc [2011] APO 79 (26 September 2011) Opposition – novelty – whether claimed method anticipated by prior published instructions and prior use where benefits of method previously unrecognised – whether ‘strict proof’ of prior use required This decision, issued by Delegate Dr B. [read post]
20 Dec 2021, 4:48 am by Ronald V. Miller, Jr.
Our firm is currently looking into potential Similac lawsuits against the formula manufacturer, Abbott Laboratories Inc., for failure to warn about the risks of NEC associated with Similac. [read post]
15 May 2012, 8:55 am by staff
“Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. [read post]
26 Jul 2012, 7:52 am
Stephen Osifo-Doe worked for Abbott Laboratories Inc. in California as a Business Analyst from July 2009 until April 2012. [read post]
15 Nov 2007, 3:21 am
Church & Dwight, Inc., No. 07 C 3428, 2007 WL 3120007 (N.D. [read post]
28 Dec 2008, 2:24 pm
Abbott Laboratories et al.6:08-cv-00507; filed December 24, 2008 in the Eastern District of TexasInfringement of U.S. [read post]